Publication dates

All regions

Cystic Fibrosis Industry, October 2014 Market Research & Statistics

You might be interested in: drug, vaccine, medicine, more »

1-10 of about 500 reports for Cystic Fibrosis

Medicine Markets in the US

  • Declining Medicine Use and Costs: for Better or Worse?
  • May 2013
    54 pages
  • Medicine  

  • United States  

View report >

Medicine Markets in the US

  • Declining Medicine Use and Costs: for Better or Worse?
  • May 2013
    56 pages
  • Medicine  

  • United States  

View report >

Global Drug Markets - Forecast

  • Orphan Drug Report 2013
  • January 2013
    19 pages
  • Drug  

  • World  

    United States  

    Europe  

View report >

Global Drug Demand Forecast

  • Orphan Drug Report 2013
  • January 2013
    19 pages
  • Drug  

  • World  

    Europe  

    United States  

View report >

Hospital Industry in the US

  • May 2013
    91 pages
  • Pediatric  

    Hospital  

  • United States  

View report >

Healthcare Markets in the US

  • The State Budget
  • February 2014
    17 pages
  • Healthcare  

    Managed Care  

  • United States  

View report >

Hospital Market in the US

  • Statistical Brief #169
  • January 2013
    12 pages
  • Hospital  

    Asthma  

  • United States  

    North America  

View report >

Pathology Description in the US - Forecast

  • Abbvie and Galapagos Extend Glpg0634 Collaboration to Include Cr...
  • May 2013
    4 pages
  • Crohn's Disease  

View report >

Pathology Description in Ireland - Forecast

  • Lung Disease in Ireland - Prevalence and Trends: Implications fo...
  • January 2013
    9 pages
  • Pathology  

    Respiratory Dis...  

  • Ireland  

    Europe  

View report >

Antibiotic Markets in the US

  • Small-cap Research
  • April 2014
    27 pages
  • Antibiotic  

    Anti-infective  

  • United States  

    Slovenia  

View report >
61 reports for Cystic Fibrosis

Purchase Reports From Reputable Market Research Publishers
(From $ 90 - $ 7 995)

Galapagos NV (Symbol:GLPGA) SWOT Analysis, Strategy, Revenues and Profits

Galapagos NV (Symbol:GLPGA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.